Production and Purification of Baculovirus for Gene Therapy Application

作者： Md Nasimuzzaman1,2, Johannes C.M. van der Loo1,2,3, Punam Malik1,2 1Division of Experimental Hematology and Cancer Biology,Cincinnati Children's Hospital Medical Center, 2University of Cincinnati College of Medicine, 3Raymond G. Perelman Center for Cellular and Molecular Therapeutics,The Children's Hospital of Philadelphia

简介：

Overview

This protocol outlines the production and purification of baculovirus using insect cell culture. The baculovirus is purified through heparin affinity chromatography and concentrated via ultracentrifugation, making it suitable for gene therapy applications.

Key Study Components

Area of Science

• Gene therapy
• Viral vector production
• Insect cell culture

Background

• Baculovirus can be used for in vivo gene transfer or as a vaccine.
• Contaminating cellular debris may induce inflammation or immune responses.
• Purification is essential to avoid toxicity in therapeutic applications.
• This method is beneficial for researchers needing concentrated baculovirus.

Purpose of Study

• To produce baculovirus in a serum-free suspension culture.
• To purify baculovirus to eliminate contaminants.
• To provide a reliable method for gene therapy applications.

Methods Used

• Transient transfection of baculovirus plasmid into Sf9 cells.
• Amplification of baculovirus in serum-free culture.
• Purification using heparin affinity chromatography.
• Concentration through ultracentrifugation.

Main Results

• Successfully produced and purified baculovirus.
• Eliminated cellular debris and proteins from the final product.
• Demonstrated the feasibility of using baculovirus for gene therapy.
• Provided a clear protocol for researchers in the field.

Conclusions

• The protocol is effective for baculovirus production and purification.
• It addresses potential toxicity issues associated with contaminants.
• This method can enhance the safety and efficacy of gene therapy applications.

Frequently Asked Questions